[ad_1]

  • Farmakis, D., Stafylas, P., Giamouzis, G., Maniadakis, N. & Parissis, J. The medical and socioeconomic burden of heart failure: A comparative delineation with cancer. Int. J. Cardiol. 15(203), 279–281 (2016).

    Article 

    Google Scholar 

  • Savarese, G. et al. Global burden of heart failure: A comprehensive and updated review of epidemiology. Cardiovasc. Res. 118(17), 3272–3287 (2023).

    Article 
    PubMed 

    Google Scholar 

  • Okura, Y. et al. Impending epidemic: Future projection of heart failure in Japan to the year 2055. Circ. J. 72(3), 489–491 (2008).

    Article 
    PubMed 

    Google Scholar 

  • Rugiómez, A., Michel, A., Martín-Pérez, M. & Rodríguez, L. A. G. Heart failure hospitalization: An important prognostic factor for heart failure re-admission and mortality. Int. J. Cardiol. 220, 855–861 (2016).

    Article 

    Google Scholar 

  • Bello, N. A. et al. Influence of previous heart failure hospitalization on cardiovascular events in patients with reduced and preserved ejection fraction. Circ. Heart Fail. 7(4), 590–595 (2014).

    Article 
    PubMed 
    PubMed Central 

    Google Scholar 

  • Jackson, S. L. et al. National burden of heart failure events in the United States, 2006 to 2014. Circ. Heart Fail. 11(12), e004873 (2018).

    Article 
    PubMed 
    PubMed Central 

    Google Scholar 

  • Störk, S. et al. Epidemiology of heart failure in Germany: A retrospective database study. Clin. Res. Cardiol. 106(11), 913–922 (2017).

    Article 
    PubMed 
    PubMed Central 

    Google Scholar 

  • Parizo, J. T., Kohsaka, S., Sandhu, A. T., Patel, J. & Heidenreich, P. A. Trends in readmission and mortality rates following heart failure hospitalization in the Veteran Affairs Health Care System from 2007 to 2017. JAMA Cardiol. 5(9), 1042–1047 (2020).

    Article 
    PubMed 

    Google Scholar 

  • Ide, T. et al. Clinical characteristics and outcomes of hospitalized patients with heart failure from the large-scale Japanese registry of acute decompensated heart failure (JROADHF). Circ. J. 85(9), 1438–1450 (2021).

    Article 
    PubMed 

    Google Scholar 

  • Akita, K. et al. Prognostic impact of previous hospitalization in acute heart failure patients. Circ. J. 83(6), 1261–1268 (2019).

    Article 
    PubMed 

    Google Scholar 

  • Heidenreich, P. A. et al. 2022 AHA/ACC/HFSA guideline for the management of heart failure: a report of the American Colledge of Cardiology/American heart Association joint committee on clinical practice guidelines. Circulation. 145(18), e895–e1032 (2022).

    PubMed 

    Google Scholar 

  • McDonagh, T. A. et al. 2021 ESC guidelines for the diagnosis and treatment of acute and chronic heart failure. Eur. Heart J. 42(36), 3599–3726 (2021).

    Article 
    CAS 
    PubMed 

    Google Scholar 

  • Tsutsui, H. et al. JCS/JHFS 2021 guideline focused update on diagnosis and treatment of acute and chronic heart failure. J. Cardiac. Fail. 27(12), 1404–1444 (2021).

    Article 

    Google Scholar 

  • Greene, S. J. et al. Clinical effectiveness of sacubitril/varsartan among patients hospitalized for heart failure with reduce ejection fraction. J. Am. Heart Assoc. 10(16), e021459 (2021).

    Article 
    CAS 
    PubMed 
    PubMed Central 

    Google Scholar 

  • Wirtz, H. S. et al. Real-world analysis of guideline-based therapy after hospitalization for heart failure. J. Am. Heart Assoc. 9(16), e015042 (2020).

    Article 
    PubMed 
    PubMed Central 

    Google Scholar 

  • Greene, S. J. et al. Medical therapy during hospitalization for heart failure with reduced ejection fraction. J. Cardiac. Fail. 28(7), 1063–1077 (2022).

    Article 

    Google Scholar 

  • D’Amario, D. et al. Assoctiation between dosing and combination use of medications and outcomes in heart failure with reduced ejection fraction: data from the Swedish heart failure registry. Eur. J. Heart Fail. 24(5), 871–884 (2022).

    Article 
    CAS 
    PubMed 

    Google Scholar 

  • Greene, S. J. et al. Medical therapy for heart failure with reduced ejection fraction: The CHAMP-HF registry. J. Am. Coll. Cardiol. 72(4), 351–366 (2018).

    Article 
    PubMed 

    Google Scholar 

  • Peri-Okonny, P. A. et al. Target doses of heart failure medical therapy and blood presure: Insights from the CHAMP-HF registry. JACC Heart Fail. 7(4), 350–358 (2019).

    Article 
    PubMed 
    PubMed Central 

    Google Scholar 

  • Ito, M. et al. Association between class of foundational medication for heart failure and prognosis in heart failure with reduced/mildly reduced ejection fraction. Sci. Rep. 12(1), 16611 (2022).

    Article 
    ADS 
    PubMed 
    PubMed Central 

    Google Scholar 

  • Savarese, G. et al. Heart failuredrug treatment – inertia, titration, and discontinuation: A multinational observational study (EVOLUTION HF). JACC Heart Fail. 11(1), 1–14 (2023).

    Article 
    PubMed 

    Google Scholar 

  • Kaneko, H. et al. Characteristics and outcomes of super-elderly patients (aged ≥ 90 yeas) hospitalized for heart failure analysis of a nationwide inpatient database. Circ. Rep. 2(8), 393–399 (2020).

    Article 
    PubMed 
    PubMed Central 

    Google Scholar 

  • Setoguchi, S., Stevenson, L. W. & Schneeweiss, S. Repeated hospitalizations predict mortality in the community population with heart failure. Am. Heart J. 154(2), 260–266 (2007).

    Article 
    PubMed 

    Google Scholar 

  • Zomer, A. C. et al. Heart failure admissions in adults with congenital heart disease; risk factors and prognosis. Int. J. Cardiol. 168(3), 2487–2493 (2013).

    Article 
    CAS 
    PubMed 

    Google Scholar 

  • Eguchi, S. et al. Burden of repeated hospitalizations on patients with heart failure: An analysis of administrative and claims data in Japan. Drugs Real World Outcomes. 9(3), 377–389 (2022).

    Article 
    PubMed 
    PubMed Central 

    Google Scholar 

  • Hayashida, K., Murakami, G., Matsuda, S. & Fushimi, K. History and profile of diagnosis procedure combination (DPC): Development of a real data collection system for acute inpatient care in Japan. J. Epidemiol. 31(1), 1–11 (2021).

    Article 
    PubMed 
    PubMed Central 

    Google Scholar 

  • Louks, J. et al. Proportions of days covered as a measure of medication adherence. Am. J. Heath-Syst. Pharm. 79(6), 492–496 (2022).

    Article 

    Google Scholar 

  • von Elm, E. et al. The strengthening the reporting of observational studies in epidemiology (STROBE) statement: Guidelines for reporting observational studies. Ann. Int. Med. 147(8), 573–577 (2007).

    Article 

    Google Scholar 

  • Ministry of Labour, Health and Welfare of Japan. Ethical Guidelines for Medical and Health Research Involving Human Subjects. https://www.mhlw.go.jp/file/06-Seisakujouhou-10600000-Daijinkanboukouseikagakuka/0000080278.pdf. Accessed on 27 Dec 2023.

  • Tsutsui, H. et al. JCS 2017/JHFS 2017 guideline of diagnosis and treatment of acute and chronic heart failure. Circ. J. 83(10), 2084–2184 (2019).

    Article 
    PubMed 

    Google Scholar 

  • Yasuda, S. et al. The current status of cardiovascular medicine in Japan: Analysis of a large number of health records from a nationwide claim-based database. Circ. J. 80(11), 2327–2335 (2016).

    Article 
    PubMed 

    Google Scholar 

  • Baxter, A. J. et al. β blockers in older persons with heart failure: Torelability and impact of quality of life. Heart. 88(6), 611–614 (2002).

    Article 
    CAS 
    PubMed 
    PubMed Central 

    Google Scholar 

  • Verhestraeten, C., Heggermont, W. A. & Michael, M. Clinical inertia in the treatment of heart failure: A major issue to tackle. Heart Fail. Rev. 26(6), 1359–1370 (2021).

    Article 
    CAS 
    PubMed 

    Google Scholar 

  • Packer, M. & Metra, M. Guideline-directed medical therapy for heart failure does not exist: A non-judgmental framework for describing the level of adherence to evidence-based drug treatments for patients with a reduced ejection fraction. Eur. J. Heart Fail. 22(10), 1759–1767 (2020).

    Article 
    PubMed 

    Google Scholar 

  • Tang, K. L., Quan, H. & Rabi, D. M. Measuring medication adherence in patients with incident hypertension: A retrospctive cohort study. BMC Health Serv. Res. 17(1), 135 (2017).

    Article 
    PubMed 
    PubMed Central 

    Google Scholar 

  • Savarese, G. et al. Heart failure drug titration, discontinuation, mortality and heart failure hospitalization risk: A multinational observational study (US, UK, and Sweden). Eur. J. Heart Fail. 23(9), 1499–1511 (2021).

    Article 
    CAS 
    PubMed 

    Google Scholar 

  • Chang, L. L. et al. Timing of post discharge follow-up and medication adherence among patients with heart failure. J. Am. Heart Assoc. 7(7), e007998 (2018).

    Article 
    PubMed 
    PubMed Central 

    Google Scholar 

  • Nakai, M. et al. Age-dependent association of discharge heart-failure medications with clinical outcomes in a super-aged society. Biomed. Pharmacother. 155, 113761 (2022).

    Article 
    PubMed 

    Google Scholar 

  • Bakal, J. A., McAlister, F. A., Liu, W. & Ezekowitz, J. A. Heart failure re-admission: Measuring the ever shortening gap between repeat heart failure hospitalizations. PLoS ONE. 9(9), e106494 (2014).

    Article 
    ADS 
    PubMed 
    PubMed Central 

    Google Scholar 

  • Butler, J. et al. Clinical course of patients with worsening heart failure with reduced ejection fraction. J. Am. Coll. Cardiol. 73(8), 935–944 (2019).

    Article 
    PubMed 

    Google Scholar 

  • Tromp, J. et al. A systematic review and network meta-analysis of pharmacological treatment of heart failure with reduce ejection fraction. JACC Heart Fail. 10(2), 73–84 (2022).

    Article 
    PubMed 

    Google Scholar 

  • Mebazaa, A. et al. Safety, torelability, and efficacy of up-titration of guideline directed medical therapies for acute heart failure (STRONG-HF): A multinational, open-label, randomised, trial. Lancet. 400(10367), 1938–1952 (2022).

    Article 
    CAS 
    PubMed 

    Google Scholar 

  • Reif, S. et al. Supporting patients with heart failure with digital therapeutics: A pilot study in Germany. Digit. Health. 8, 20552076221143900 (2022).

    CAS 
    PubMed 
    PubMed Central 

    Google Scholar 

  • Denis, F. et al. Two-year survival comparing web-based symptom monitoring vs routine surveillance following treatment for lung cancer. JAMA. 321(3), 306–307 (2019).

    Article 
    PubMed 
    PubMed Central 

    Google Scholar 

  • Maclnnes, J. & Williams, L. A review of integrated heart failure care. Prim. Health Care Res. Dev. 20, e57 (2019).

    Article 

    Google Scholar 

  • [ad_2]

    Source link